Abstract
The purpose of this study is to analyze the influence of the financial structure of pharmaceutical companies on R&D investment. 358 pharmaceutical firms listed in the KOSDAQ market from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price was extracted from KISVALUE-Ⅲ of NICE Information Service Co., Ltd. STATA 12.0 was used as the statistical package for panel analysis. The summary of the findings and the interpretation of the significance of this are as follows: First, the shareholding ratio of major shareholders and foreigners had a positive influence on R&D investment. Second, the ratio of outside directors had a negative influence on R&D investment. Third, the shareholding ratio of institutional investors did not have a significant influence on R&D investment.
Cite
CITATION STYLE
Lee, M., & Choi, M. (2015). The Relationship between R&D investment and Ownership Structure in KOSDAQ Pharmaceutical Firms. The Journal of the Korea Contents Association, 15(6), 445–454. https://doi.org/10.5392/jkca.2015.15.06.445
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.